Literature DB >> 11994445

A role for CD147 in thymic development.

Toufic Renno1, Anne Wilson, Caroline Dunkel, Isabelle Coste, Karine Maisnier-Patin, Amélie Benoit de Coignac, Jean-Pierre Aubry, Rosemary K Lees, Jean-Yves Bonnefoy, H Robson MacDonald, Jean-François Gauchat.   

Abstract

We have previously identified a mAb that binds to a molecule expressed preferentially on the surface of cycling thymocytes. In this study the molecule recognized by this mAb has been identified in the mouse as CD147 (basigin) by expression cloning. We show that CD147 expression correlates with cycling of immature thymocytes even in the absence of TCRbeta selection and that ligation of this molecule on immature fetal thymocytes inhibits their further development into mature T cells.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11994445     DOI： 10.4049/jimmunol.168.10.4946

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


  23 in total

1.  Mammalian target of rapamycin complex 2 modulates αβTCR processing and surface expression during thymocyte development.

Authors:  Po-Chien Chou; Won Jun Oh; Chang-Chih Wu; Joseph Moloughney; Markus A Rüegg; Michael N Hall; Estela Jacinto; Guy Werlen
Journal:  J Immunol       Date:  2014-06-30       Impact factor: 5.422

2.  Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion.

Authors:  Peter Seizer; Carmen Ochmann; Tanja Schönberger; Sebastian Zach; Melanie Rose; Oliver Borst; Karin Klingel; Reinhard Kandolf; H Robson MacDonald; Romana A Nowak; Stefan Engelhardt; Florian Lang; Meinrad Gawaz; Andreas E May
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03-24       Impact factor: 8.311

3.  A miRNA-492 binding-site polymorphism in BSG (basigin) confers risk to psoriasis in central south Chinese population.

Authors:  Li-Sha Wu; Fang-Fang Li; Liang-Dan Sun; Dai Li; Juan Su; Ye-Hong Kuang; Gang Chen; Xiao-Ping Chen; Xiang Chen
Journal:  Hum Genet       Date:  2011-06-08       Impact factor: 4.132

4.  Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention.

Authors:  William M Gwinn; Jesse M Damsker; Rustom Falahati; Ifeanyi Okwumabua; Ann Kelly-Welch; Achsah D Keegan; Christophe Vanpouille; James J Lee; Lindsay A Dent; David Leitenberg; Michael I Bukrinsky; Stephanie L Constant
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

5.  Extracellular cyclophilins contribute to the regulation of inflammatory responses.

Authors:  Kamalpreet Arora; William M Gwinn; Molly A Bower; Alan Watson; Ifeanyi Okwumabua; H Robson MacDonald; Michael I Bukrinsky; Stephanie L Constant
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

Review 6.  CD147 and glioma: a meta-analysis.

Authors:  Hui Li; Zhouhuan Xi; Xuejiao Dai; Wenyue Wu; Yanwen Li; Yanting Liu; Hanwen Zhang
Journal:  J Neurooncol       Date:  2017-05-30       Impact factor: 4.130

Review 7.  Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics.

Authors:  V Yurchenko; S Constant; E Eisenmesser; M Bukrinsky
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

8.  Links between CD147 function, glycosylation, and caveolin-1.

Authors:  Wei Tang; Sharon B Chang; Martin E Hemler
Journal:  Mol Biol Cell       Date:  2004-06-16       Impact factor: 4.138

Review 9.  CD147 immunoglobulin superfamily receptor function and role in pathology.

Authors:  Kathryn T Iacono; Amy L Brown; Mark I Greene; Sandra J Saouaf
Journal:  Exp Mol Pathol       Date:  2007-09-07       Impact factor: 3.362

Review 10.  Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.

Authors:  Julieta Afonso; Lúcio L Santos; Adhemar Longatto-Filho; Fátima Baltazar
Journal:  Nat Rev Urol       Date:  2020-01-17       Impact factor: 14.432
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.